Clinical trials recruiting for KRAS G12D
3
Recruiting trials
23
US states with sites
6
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 1 3Phase 2 1
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 3 |
| Massachusetts | 3 |
| New York | 3 |
| Tennessee | 3 |
| Texas | 3 |
| Connecticut | 2 |
| Florida | 2 |
| Illinois | 2 |
| Missouri | 2 |
| Washington | 2 |
| Arizona | 1 |
| Colorado | 1 |
Top cities
Boston, Massachusetts 3Houston, Texas 3Los Angeles, California 3Nashville, Tennessee 3New York, New York 3Dallas, Texas 2New Haven, Connecticut 2San Antonio, Texas 2San Francisco, California 2Seattle, Washington 2
Self-screener
Recruiting trials
- BBO-11818 in Adult Subjects With KRAS Mutant Cancer
- Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
- Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Related conditions
Trials recruiting for KRAS G12D often also study these conditions. Each links to its own recruiting-trial list.
Non-small cell lung cancer 507Lung cancer 2180Colorectal cancer 1359Solid Tumor, Adult 38Pancreatic cancer 870Colorectal Carcinoma 42Thyroid Carcinoma 3Thyroid Cancer 21Solid Carcinoma 6Recurrent Lung Non-Small Cell Carcinoma 12
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for KRAS G12D trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.